This report represents a set of analytic studies of patients having stages III-B and IV Hodgkin's disease who were treated with sequential therapy with single agents over a ten-year period. The objectives of these studies were to establish statistical models both for disease characterization and for
β¦ LIBER β¦
Response to bcg vaccination and survival in advanced Hodgkin's disease
β Scribed by Joseph E. Sokal; C. William Aungst
- Book ID
- 102665075
- Publisher
- John Wiley and Sons
- Year
- 1969
- Tongue
- English
- Weight
- 586 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Prediction and analysis of survival in a
β
Jack Brook; Edward E. Gocka
π
Article
π
1972
π
Elsevier Science
π
English
β 928 KB
BCG in the immunotherapy of Hodgkin's di
β
B. HΕrni; J. Chauvergne; G. HΕrni-Simon; M. Durand; R. Brunet; C. Lagarde
π
Article
π
1976
π
Springer-Verlag
π
English
β 232 KB
Antibody response to pneumococcal vaccin
β
Birgitte Frederiksen; Lena Specht; JΓΈrgen Henrichsen; Freddy Karup Pedersen; Jen
π
Article
π
2009
π
John Wiley and Sons
π
English
β 334 KB
Lymphocyte response to phytohemagglutini
β
Tin Han; Joseph E. Sokal
π
Article
π
1970
π
Elsevier Science
π
English
β 580 KB
Extralymphatic Hodgkin's disease: Progno
β
Frank M. Torti; Carol S. Portlock; Saul A. Rosenberg; Henry S. Kaplan
π
Article
π
1981
π
Elsevier Science
π
English
β 612 KB
Factors affecting remission and survival
β
Dr. John Wagstaff; William Steward; Mary Jones; David Deakin; Ian Todd; Peter Wi
π
Article
π
1986
π
John Wiley and Sons
π
English
β 786 KB
One hundred and fourteen patients with clinical or pathological stages IIIB and IV Hodgkin's disease have been treated with MVPP chemotherapy followed by radiotherapy to sites of previously bulky disease. The minimum follow-up is 2 years with a median of 5 years. The overall remission rate was 92 pe